AI-powered platform accelerating clinical trial recruitment by matching patient profiles with trial criteria through real-time EMR analysis, reducing recruitment time by 40-60% for pharma companies and research organizations.
BioMatch AI revolutionizes clinical trial recruitment by leveraging artificial intelligence to analyze electronic medical records in real-time. This platform solves the critical bottleneck of patient enrollment – which delays 85% of trials – through proprietary matching algorithms that identify eligible candidates 40-60% faster than manual processes while ensuring full HIPAA/GDPR compliance.
Core functionality
AI-driven analysis of Electronic Medical Records (EMR) and patient registries using NLP to match profiles with trial criteria. Features include automated screening, real-time matching, HIPAA-compliant data handling, sponsor analytics dashboards, and blockchain-secured consent management.
Target user and segment
Pharmaceutical companies (60% focus), clinical research organizations (30%), and academic research institutions (10%). Specializes in oncology, rare diseases, and neurology trials where patient recruitment is most challenging.
Recommended tech stack
- Backend: Python/Django
- Frontend: React.js
- EMR Integration: FHIR API
- AI Models: TensorFlow NLP
- Database: PostgreSQL
- Infrastructure: AWS HIPAA-compliant
- Security: Blockchain audit trails
Estimated MVP hours and costs
1,800 development hours at €100/hour = €180,000 investment:
- Backend: 700h (€70,000)
- Frontend: 400h (€40,000)
- AI/ML: 500h (€50,000)
- Compliance: 200h (€20,000)
SWOT-analysis
| Strengths | 40-60% faster recruitment, proprietary algorithms, major EMR integrations |
|---|---|
| Weaknesses | Regulatory complexity, hospital data dependency, high implementation cost |
| Opportunities | €69B global trials market, decentralized trial growth, pharma digitalization |
| Threats | Established players (Medidata, IBM), privacy regulations, data silos |
First 1000 customers strategy
Acquisition channels:
- Pharma trade shows (40% allocation)
- LinkedIn outreach to clinical ops directors (30%)
- CRO co-marketing (20%)
- Research hospital partnerships (10%)
Cost: €250 CAC = €250,000 total. Projected 5% conversion rate via dedicated sales team.
Monetization
Tiered SaaS model:
- Basic: €2,000/trial
- Pro: €5,000/trial + % savings
- Enterprise: Custom pricing
Break-even: 90 Pro-tier trials (€450k ARR). Scales to €4M ARR at 800 trials. Core team: 6 FTE (2 devs, 1 AI specialist, 1 compliance, 1 sales, 1 CX).
Market positioning and competitors
Regional markets: North America (€12.5B), Europe (€8.2B), Asia-Pacific (€6.7B). Competitors include Deep 6 AI and IBM Clinical Trial Matching. Differentiation through real-time EMR processing and predictive recruitment forecasting. Sales strategy: ROI-focused solution selling capturing 20-40% of client recruitment savings.
